Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Sertindole: dilemmas for its use in clinical practice.

Pae CU.

Expert Opin Drug Saf. 2013 May;12(3):321-6. doi: 10.1517/14740338.2013.773971. Epub 2013 Feb 25.

PMID:
23432404
2.

Sertindole for schizophrenia.

Lewis R, Bagnall AM, Leitner M.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001715. Review.

PMID:
16034864
3.

Drug safety and efficacy evaluation of sertindole for schizophrenia.

Karamatskos E, Lambert M, Mulert C, Naber D.

Expert Opin Drug Saf. 2012 Nov;11(6):1047-62. doi: 10.1517/14740338.2012.726984. Epub 2012 Sep 19. Review.

PMID:
22992213
4.

A review of the safety and tolerability of sertindole.

Hale AS.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S65-70. Review.

PMID:
9690973
5.

A review of the efficacy, tolerability and safety of sertindole in clinical trials.

Perquin L, Steinert T.

CNS Drugs. 2004;18 Suppl 2:19-30; discussion 41-3. Review.

PMID:
15461313
6.

Sertindole for schizophrenia.

Lewis R, Bagnall A, Leitner M.

Cochrane Database Syst Rev. 2000;(2):CD001715. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD001715.

PMID:
10796657
7.

Efficacy and safety of sertindole in schizophrenia: a clinical review.

Zoccali RA, Bruno A, Muscatello MR.

J Clin Psychopharmacol. 2015 Jun;35(3):286-95. doi: 10.1097/JCP.0000000000000305. Review.

PMID:
25830594
8.

Sertindole in schizophrenia: efficacy and safety issues.

Muscatello MR, Bruno A, Micali Bellinghieri P, Pandolfo G, Zoccali RA.

Expert Opin Pharmacother. 2014 Sep;15(13):1943-53. doi: 10.1517/14656566.2014.947960. Epub 2014 Aug 1. Review.

PMID:
25084209
9.

Sertindole: efficacy and safety in schizophrenia.

Lindström E, Levander S.

Expert Opin Pharmacother. 2006 Sep;7(13):1825-34. Review.

PMID:
16925508
10.

Emerging treatments in the management of schizophrenia - focus on sertindole.

Muscatello MR, Bruno A, Pandolfo G, Micò U, Settineri S, Zoccali R.

Drug Des Devel Ther. 2010 Sep 7;4:187-201. doi: 10.2147/DDDT.S6591. Review.

11.

Sertindole: a review of clinical efficacy.

Kane JM.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S59-63; discussion S63-4. Review.

PMID:
9690972
12.

Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety.

Tamminga CA, Mack RJ, Granneman GR, Silber CJ, Kashkin KB.

Int Clin Psychopharmacol. 1997 Feb;12 Suppl 1:S29-35. Review.

PMID:
9179641
13.

Case histories illustrating the utility of sertindole in clinical practice.

Schuck P, van den Ameele H, Jaanson P, Ryckmans V, Hawley C.

CNS Drugs. 2004;18 Suppl 2:31-40; discussion 41-3. Review.

PMID:
15461314
14.

Sertindole : a review of its use in schizophrenia.

Murdoch D, Keating GM.

CNS Drugs. 2006;20(3):233-55. Review.

PMID:
16529528
15.

Do we need another atypical antipsychotic?

Kasper S.

Eur Neuropsychopharmacol. 2008 Aug;18 Suppl 3:S146-52. doi: 10.1016/j.euroneuro.2008.04.006. Epub 2008 May 29. Review.

PMID:
18511242
16.

Sertindole for the treatment of schizophrenia.

Azorin JM, Kaladjian A, Fakra E, Adida M.

Expert Opin Pharmacother. 2010 Dec;11(18):3053-64. doi: 10.1517/14656566.2010.536217. Review.

PMID:
21080854
17.

Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.

Fowler JA, Bettinger TL, Argo TR.

Clin Ther. 2008 Feb;30(2):231-48. doi: 10.1016/j.clinthera.2008.02.011. Review.

PMID:
18343262
18.

Lurasidone for schizophrenia: a review of the efficacy and safety profile for this newly approved second-generation antipsychotic.

Citrome L.

Int J Clin Pract. 2011 Feb;65(2):189-210. doi: 10.1111/j.1742-1241.2010.02587.x. Epub 2010 Dec 3. Review.

PMID:
21129135
19.

Sertindole: pharmacological and clinical profile and role in the treatment of schizophrenia.

Spina E, Zoccali R.

Expert Opin Drug Metab Toxicol. 2008 May;4(5):629-38. doi: 10.1517/17425255.4.5.629 . Review.

PMID:
18484920
20.

Upcoming agents for the treatment of schizophrenia: mechanism of action, efficacy and tolerability.

Bishara D, Taylor D.

Drugs. 2008;68(16):2269-92. doi: 10.2165/0003495-200868160-00002. Review.

PMID:
18973393

Supplemental Content

Support Center